MILPITAS, Calif., Feb. 1, 2017 /PRNewswire/ -- Protagonist Therapeutics, Inc. (NASDAQ: PTGX) will participate in the Leerink Partners 6th Annual Global Healthcare Conference on February 16, at Lotte New York Palace, NY. Dinesh V. Patel, Ph.D., Protagonist President and Chief Executive Officer will represent the company in a session scheduled at 11:00 am (Eastern Time).
A live audio webcast of the presentation may be accessed by visiting the Investors page of Protagonist Therapeutics corporate website at http://investors.protagonist-inc.com. A replay of the presentation will be available for 30 days following the presentation.
About Protagonist Therapeutics
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. Its primary focus is on developing first-in-class oral peptide drugs that specifically target the same biological pathways for which there are marketed injectable antibody drugs. Compared to injectable antibody drugs, Protagonist's oral peptides offer preferential drug exposure in the GI tissue compartment, the potential for improved safety due to minimal exposure in the blood, improved convenience and compliance, and potentially an opportunity for the earlier introduction of targeted therapy for inflammatory bowel disease (IBD). Protagonist's oral peptide product candidates, PTG-100 and PTG-200, are based on this approach with the potential to transform the existing treatment paradigm for IBD, which includes both ulcerative colitis and Crohn's disease.
Protagonist is headquartered in Milpitas, California with its pre-clinical and clinical development staff in California, and discovery operations both in California and in Brisbane, Queensland, Australia. For further information, please visit http://www.protagonist-inc.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/protagonist-therapeutics-to-participate-in-the-leerink-partners-6th-annual-global-healthcare-conference-300400273.html
SOURCE Protagonist Therapeutics, Inc.